Related Experiment Video

Updated: Nov 16, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.8K

STING-Induced Inflammation - A Novel Therapeutic Target in ALS?

Philip Van Damme1, Wim Robberecht1

  • 1From VIB, Center for Brain and Disease Research, Laboratory of Neurobiology (P.V.D.), the Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute, KU Leuven-University of Leuven, and the Department of Neurology, University Hospitals Leuven (P.V.D., W.R.), Leuven, Belgium.

The New England Journal of Medicine
|February 24, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.2K
Author Spotlight: Insight Into Advances in Prion Diseases Research10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

673

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
566